InvestorsHub Logo
Followers 29
Posts 940
Boards Moderated 0
Alias Born 03/10/2014

Re: Angry Goat post# 96830

Wednesday, 03/12/2014 12:18:42 PM

Wednesday, March 12, 2014 12:18:42 PM

Post# of 130502
New to the site, enjoy the posts, and long on AMBS!

I too would like to offer up my thoughts...
We who are holding Tens of thousands if not Millions of shares are very excited about the news of financing. And awaiting some big news from GC.
With all the new Orphans in the rough, and only Eltoprazine in current studies, I believe the next major announcement will be a Phase 2B study for PD LID or Adult ADHD...IMO

I don't see anything else that could be close for news.
(Taken from the Q1-2014: The Maturation of Amarantus
Posted on Monday, February 24th, 2014 at 9:46 am"
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
2.Eltoprazine is expected to be entering Phase 2b later this year in Levadopa-Induced Dyskynesia (PD LID), an indication with revenue potential in excess of $750M per year in the United States alone. In addition, the Company has the opportunity to initiate a Phase 2b trial in Adult ADHD, where there is a growing need for non-scheduled, non-stimulant-based treatments. Importantly, Eltoprazine has been evaluated in over 700 patients to date, and has a very strong safety profile thereby mitigating commercial safety risk for potential partners;
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
Just my thoughts...afterall, it is "Later this year"???
Time to start enrolling patients!!!
Anyone else?